Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Efficacy, Safety, and Tolerability of Efgartigimod in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Results from the ADHERE Trial (PL5.002)

Jeffrey Allen,Ivana Basta,Christian Eggers,Jeffrey Guptill,Kelly Gwathmey,Channa Hewamadduma,Erik Hofman,Yessar Hussain,Satoshi Kuwabara,Frank Leypoldt,Jie Lin,Marta Lipowska, Murray Lowe,Giuseppe Lauria Pinter, Luis Querol,Niraja Suresh,Anissa Tse,Peter Ulrichts,Pieter Van Doorn,Benjamin Van Hoorick,Ryo Yamasaki,Richard Lewis

Neurology（2024）

Cited 0|Views13
No score
Abstract
Assess the efficacy and safety of subcutaneous (SC) efgartigimod PH20 (co-formulated with recombinant human hyaluronidase PH20) in chronic inflammatory demyelinating polyneuropathy (CIDP).
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined